Phenotype
|
Fish
|
Conditions
|
Figures
|
atrium decreased size, abnormal
|
nr2f1ael512/el512
|
chemical treatment by environment: dorsomorphin
|
Fig. S3
from Duong et al., 2017
|
atrioventricular canal bmp4 expression spatial pattern, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
cerebellum nr2f1a expression absent, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 1
from Duong et al., 2017
|
cardiac ventricle myh7 expression spatial pattern, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 2
from Duong et al., 2017
|
heart morphology, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 4
from Dohn et al., 2019
|
blood accumulation ball, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Dohn et al., 2019
|
atrioventricular canal has2 expression spatial pattern, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
hindbrain nr2f1a expression absent, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 1
from Duong et al., 2017
|
pericardium edematous, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 1
from Duong et al., 2017
|
atrium decreased size, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 2
from Duong et al., 2017
|
atrium cardiac muscle cell decreased amount, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 2
from Duong et al., 2017
|
atrioventricular canal notch1b expression spatial pattern, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
atrioventricular canal bmp4 expression increased distribution, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
pharyngeal arch nr2f1a expression absent, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 1
from Duong et al., 2017
|
atrium cardiac muscle cell decreased amount, abnormal
|
nr2f1ael512/el512
|
chemical treatment by environment: dorsomorphin
|
Fig. S3
from Duong et al., 2017
|
atrioventricular canal spp1 expression spatial pattern, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
atrioventricular canal tbx2b expression spatial pattern, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
atrium myh6 expression decreased amount, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 2
from Duong et al., 2017
|
atrioventricular canal notch1b expression increased distribution, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
cardiac ventricle myh7 expression increased distribution, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 2
from Duong et al., 2017
|
atrioventricular canal tbx2b expression increased distribution, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
atrioventricular canal spp1 expression increased distribution, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
atrioventricular canal klf2a expression increased distribution, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
atrioventricular canal has2 expression increased distribution, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
atrioventricular canal klf2a expression spatial pattern, abnormal
|
nr2f1ael512/el512
|
standard conditions
|
Fig. 3
from Duong et al., 2017
|
endocardial cushion cell increased amount, abnormal
|
nr2f1ael512/el512; f2Tg
|
chemical treatment by environment: dorsomorphin
|
Fig. 4
from Duong et al., 2017
|
atrioventricular canal increased size, abnormal
|
nr2f1ael512/el512; f2Tg
|
chemical treatment by environment: dorsomorphin
|
Fig. 4
from Duong et al., 2017
|
atrium cardiac muscle cell decreased amount, abnormal
|
nr2f1ael512/el512; sd12Tg
|
standard conditions
|
Fig. 4
from Dohn et al., 2019
|
atrial cardiac muscle cell differentiation disrupted, abnormal
|
nr2f1ael512/el512; sd22Tg
|
standard conditions
|
Fig. 2
from Duong et al., 2017
|
pectoral protractor ab-mf20 labeling decreased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/+
|
standard conditions
|
Fig. S7
from Dohn et al., 2019
|
blood accumulation ball, abnormal
|
nr2f1ael512/el512; nr2f2el506/+
|
standard conditions
|
Fig. 3
from Dohn et al., 2019
|
heart morphology, abnormal
|
nr2f1ael512/el512; nr2f2el506/+
|
standard conditions
|
Fig. 4
from Dohn et al., 2019
|
presumptive cardiac ventricle primitive heart tube cardiac muscle cell increased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/+
|
standard conditions
|
Fig. 5
from Dohn et al., 2019
|
pectoral protractor decreased size, abnormal
|
nr2f1ael512/el512; nr2f2el506/+
|
standard conditions
|
Fig. S7
from Dohn et al., 2019
|
pectoral protractor absent, abnormal
|
nr2f1ael512/el512; nr2f2el506/+
|
standard conditions
|
Fig. S7
from Dohn et al., 2019
|
pericardium edematous, abnormal
|
nr2f1ael512/el512; nr2f2el506/+
|
standard conditions
|
Fig. 3
from Dohn et al., 2019
|
cardiac ventricle cardiac muscle cell increased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/+; fb2Tg; pd42Tg
|
standard conditions
|
Fig. 8
from Dohn et al., 2019
|
cardiac ventricle cardiac muscle cell ZsYellow expression increased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/+; fb2Tg; pd42Tg
|
standard conditions
|
Fig. 8
from Dohn et al., 2019
|
pectoral protractor ZsYellow expression decreased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/+; fb5Tg; pd42Tg
|
standard conditions
|
Fig. 7
from Dohn et al., 2019
|
pectoral protractor absent, abnormal
|
nr2f1ael512/el512; nr2f2el506/+; fb5Tg; pd42Tg
|
standard conditions
|
Fig. 7
from Dohn et al., 2019
|
cardiac ventricle cardiac muscle cell increased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/+; sd12Tg
|
standard conditions
|
Fig. 4
from Dohn et al., 2019
|
pectoral protractor decreased size, abnormal
|
nr2f1ael512/el512; nr2f2el506/+; zf13Tg
|
standard conditions
|
Fig. 6
from Dohn et al., 2019
|
pectoral protractor absent, abnormal
|
nr2f1ael512/el512; nr2f2el506/+; zf13Tg
|
standard conditions
|
Fig. 6
from Dohn et al., 2019
|
pectoral protractor GFP expression decreased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/+; zf13Tg
|
standard conditions
|
Fig. 6
from Dohn et al., 2019
|
blood accumulation ball, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506
|
standard conditions
|
Fig. 3
from Dohn et al., 2019
|
heart morphology, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506
|
standard conditions
|
Fig. 4
from Dohn et al., 2019
|
heart primordium Ab3-nkx2.5 labeling increased distribution, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506
|
standard conditions
|
Fig. S4
from Dohn et al., 2019
|
heart primordium Ab3-nkx2.5 labeling increased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506
|
standard conditions
|
Fig. S4
from Dohn et al., 2019
|
presumptive cardiac ventricle primitive heart tube cardiac muscle cell increased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506
|
standard conditions
|
Fig. 5
from Dohn et al., 2019
|
pectoral protractor decreased size, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506
|
standard conditions
|
Fig. S7
from Dohn et al., 2019
|
pectoral protractor absent, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506
|
standard conditions
|
Fig. S7
from Dohn et al., 2019
|
pericardium edematous, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506
|
standard conditions
|
Fig. 3
from Dohn et al., 2019
|
pectoral protractor ab-mf20 labeling decreased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506
|
standard conditions
|
Fig. S7
from Dohn et al., 2019
|
cardiac ventricle cardiac muscle cell ZsYellow expression increased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506; fb2Tg; pd42Tg
|
standard conditions
|
Fig. 8
from Dohn et al., 2019
|
pectoral protractor ZsYellow expression decreased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506; fb5Tg; pd42Tg
|
standard conditions
|
Fig. 7
from Dohn et al., 2019
|
pectoral protractor absent, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506; fb5Tg; pd42Tg
|
standard conditions
|
Fig. 7
from Dohn et al., 2019
|
cardiac ventricle cardiac muscle cell increased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506; sd12Tg
|
standard conditions
|
Fig. 4
from Dohn et al., 2019
|
pectoral protractor decreased size, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506; zf13Tg
|
standard conditions
|
Fig. 6
from Dohn et al., 2019
|
pectoral protractor absent, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506; zf13Tg
|
standard conditions
|
Fig. 6
from Dohn et al., 2019
|
pectoral protractor GFP expression decreased amount, abnormal
|
nr2f1ael512/el512; nr2f2el506/el506; zf13Tg
|
standard conditions
|
Fig. 6
from Dohn et al., 2019
|
neural crest cell migration decreased occurrence, abnormal
|
nr2f1ael512/el512; nr2f1bel523/el523; nr2f2el506/el506; nr2f5el611/el611 (TU)
|
standard conditions
|
Fig. 2
from Barske et al., 2018
|